EBS - Emergent BioSolutions Inc.

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue782,400560,873488,782489,331
Cost of Revenue322,300293,091239,574216,845
Gross Profit460,100267,782249,208272,486
Operating Expenses
Research Development142,800142,800142,800142,800
Selling General and Administrative202,500140,957134,000121,145
Non Recurring----
Others----
Total Operating Expenses692,600434,048373,574337,990
Operating Income or Loss89,800126,825115,208151,341
Income from Continuing Operations
Total Other Income/Expenses Net-8,300-8,192-15,987-15,625
Earnings Before Interest and Taxes89,800126,825115,208151,341
Interest Expense-9,900-6,590-7,617-6,523
Income Before Tax81,500118,63399,221135,716
Income Tax Expense18,80036,03936,69744,300
Minority Interest----
Net Income From Continuing Ops62,70082,59462,52491,416
Non-recurring Events
Discontinued Operations---10,748-28,546
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income62,70082,59451,77662,870
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares62,70082,59451,77662,870